Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients Read more about Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
Information on the total number of voting rights and shares Read more about Information on the total number of voting rights and shares
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results Read more about Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
Information on the total number of voting rights and shares Read more about Information on the total number of voting rights and shares
Publication relating to transparency notifications Read more about Publication relating to transparency notifications
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026 Read more about Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
Publication relating to transparency notifications Read more about Publication relating to transparency notifications
Information on the total number of voting rights and shares Read more about Information on the total number of voting rights and shares
Nyxoah Announces Closing of Underwritten Public Offering Read more about Nyxoah Announces Closing of Underwritten Public Offering
Nyxoah Announces Pricing of $95 Million Underwritten Public Offering Read more about Nyxoah Announces Pricing of $95 Million Underwritten Public Offering